Syon Capital’s Tandem Diabetes Care TNDM Stock Holding History

Syon Capital’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,437	Closed	-$219K	–	1006
2026 Q1	$219K	Buy	+11,437	New	+$249K	0.01%	854

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Syon Capital's TNDM Position: Q2 2026 in Review

Syon Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 11,437 shares — an estimated $219K sold.

Syon Capital first reported a position in TNDM in Q1 2026 and held it in 1 quarter. The position peaked at $219K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Syon Capital reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
Syon Capital sold 11,437 Tandem Diabetes Care shares in Q2 2026, an estimated $219K.
Syon Capital first reported a position in Tandem Diabetes Care in Q1 2026 and held it in 1 quarter.
Syon Capital's Tandem Diabetes Care position peaked at $219K in Q1 2026.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.